When Northwestern Medicine researchers engineered mice to produce less of a molecule called L-2-hydroxyglutarate, something unexpected happened: the animals grew poorly, their kidneys developed abnormally, and many died. For decades, this compound—known as L-2-HG—had been written off as nothing but toxic waste, a byproduct of metabolism that cells worked to eliminate. But a new study published in Nature reveals it is something far more essential: a signaling molecule that directly controls genes and shapes early development.
The discovery challenges a fundamental assumption in biochemistry. Navdeep Chandel, a professor of Biochemistry and Molecular Genetics at Northwestern Medicine and senior author of the study, puts it plainly: "This metabolite previously was described as a toxic metabolite, and not part of regular physiology." Yet his team found that L-2-HG is involved in kidney development and plays a crucial role in regulating which genes are switched on or off during growth.
The breakthrough came from mapping how L-2-HG interacts with proteins inside cells. The researchers, working with collaborator Ali Shilatifard, discovered that L-2-HG targets a family of enzymes called KDM4 demethylases. By inhibiting these enzymes, L-2-HG increases histone H3K9me3—a repressive histone mark that silences gene transcription at specific sites. Think of it as a dimmer switch for genes: when L-2-HG is present, certain genes stay shut down. When it vanishes, those genes turn back on.
In healthy cells, an enzyme called L-2-HG dehydrogenase keeps L-2-HG levels extremely low by converting it into another compound, 2-oxoglutarate. This tight control is so important that when the conversion fails in humans, the buildup of L-2-HG causes a rare neurological disorder. But as the Northwestern team's work shows, the reason for this control is not that L-2-HG is inherently harmful—it is that L-2-HG needs to be carefully managed to do its job properly.
The implications extend beyond kidney development. The researchers found that L-2-HG also controls the activity of retrotransposons, which are genetic elements that can trigger dangerous inflammation if activated. When L-2-HG levels are high, these elements stay silenced. When the molecule is depleted, retrotransposons awaken, potentially sparking inflammation. This discovery links metabolism directly to the control of genomic elements scientists had not previously thought were metabolically regulated.
Chandel emphasizes how this reframes our understanding of metabolism itself. "We generally think everything is about your genes," he said. "And then there's metabolism, that's just for energy. What we found is that your mitochondria can also dictate those gene responses. It's just not a passive player." Rather than simply burning fuel to power cells, metabolism actively communicates with a cell's nucleus to determine what that cell becomes.
The findings open new doors for understanding how metabolites influence health and disease. If a molecule long dismissed as toxic waste turns out to be essential, what other overlooked metabolites might be doing the same? As Chandel notes, the discovery exemplifies a broader shift in scientific thinking: "This is probably one of our cleanest examples. This molecule is made, it does its job, then it goes away. And it's necessary for kidney development specifically." That clarity may help researchers identify other metabolites that secretly orchestrate development and health.